Protagonist Therapeutics grants new hires options for 7,300 shares, RSUs for 1,975 shares at $136.64 strike price
PTGX•Inducement awards for two new employees
Protagonist Therapeutics granted inducement equity awards on July 31, 2026 to two newly hired employees.
The awards total options for 7,300 shares and RSUs for 1,975 shares under its amended inducement plan.
The options carry a $136.64 exercise price, matching the Nasdaq closing price on July 31.
The options vest over four years: 25% after one year, with the remainder vesting monthly over three years. The RSUs vest 25% annually over four years.
